Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 670,952 | 237,677 | 144,052 | 100,150 | 20,950 |
| Marketable Securities | 178,951 | 193,692 | 147,260 | 177,077 | 118,740 |
| Receivables | 26,101 | 8,547 | 7,039 | 3,570 | 3,234 |
| TOTAL | $893,269 | $449,916 | $306,013 | $285,243 | $146,786 |
| Non-Current Assets | |||||
| PPE Net | 7,768 | 6,812 | 7,106 | 6,966 | 5,201 |
| Investments And Advances | 7,585 | 22,477 | 0 | 95,723 | 94,692 |
| Other Non-Current Assets | 23,715 | 25,701 | 1,702 | 1,245 | 968 |
| TOTAL | $39,068 | $54,990 | $8,808 | $103,934 | $100,861 |
| Total Assets | $932,337 | $504,906 | $314,821 | $389,177 | $247,647 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,472 | 2,295 | 419 | 1,086 | 1,590 |
| Accrued Expenses | 44,681 | 24,895 | 18,209 | 14,936 | 13,249 |
| TOTAL | $60,163 | $33,373 | $18,912 | $16,745 | $16,149 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 284 | 723 | 1,310 |
| Other Non-Current Liabilities | 17,067 | 22,057 | 1,491 | 2,236 | 1,244 |
| TOTAL | $17,067 | $22,057 | $3,872 | $7,215 | $5,901 |
| Total Liabilities | $77,230 | $55,430 | $22,784 | $23,960 | $22,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,550 | 53,337 | 51,690 | 45,419 | 38,395 |
| Common Shares | 60 | 53 | 47 | 46 | 39 |
| Retained earnings | -877,437 | -711,407 | -586,549 | -473,024 | -364,491 |
| Other shareholders' equity | -288 | 23 | -560 | -895 | -425 |
| TOTAL | $855,107 | $449,476 | $292,037 | $365,217 | $225,597 |
| Total Liabilities And Equity | $932,337 | $504,906 | $314,821 | $389,177 | $247,647 |